Annual Meeting Agenda - 2022 Annual Meeting

Coding and Reimbursement Symposium

Moderator: Richard Fine, MD, FACS

Welcome and Introduction
Richard Fine, MD, FACS
Implementation of 2021 EM Codes: Does My Documentation Meet the Appropriate Levels? Based on MDM vs Based on Time
Linda Han, MD, FACS, FSSO; Terry Sarantou, MD, FACS
Coding Issues From “My Biller”: From Intra-operative Localization to ATT
Richard Fine, MD, FACS
How Do I Code This?
Walton Taylor, MD, FACS
Q&A

The John Wayne Critical Issues in Breast Cancer Forum: Breast Cancer Post-COVID

Supported by a grant from the John Wayne Cancer Foundation

Moderator: Dennis Holmes, MD, FACS

Welcome and Introduction
Dennis Holmes, MD, FACS
Screening Delays: Will We See Stage Migration?
Jill Dietz, MD, FACS
The Ethics of Delaying Surgery
Toan Nguyen, MD, FACS
Impact of COVID on Timing of Multigene Assays
Judy Boughey, MD, FACS
The Same Day Mastectomy
Lee Wilke, MD, FACS
Q&A

High-Risk Clinic

Moderator: Peter Beitsch, MD, FACS

Welcome and Introduction
Peter Beitsch, MD, FACS
Making Sense of Risk Models for Breast Cancer
Amy Cyr, MD, FACS
Risk-Reducing Medications
Amy Cyr, MD, FACS
Minimizing Risk With Diet and Exercise
Tarah Ballinger, MD
When Should We Offer Preventative Mastectomy?
Todd Tuttle, MD, FACS
Q&A

Breast Imaging in 2022

Moderator: Souzan El-Eid, MD, FACS

Welcome and Introduction
Souzan El-Eid, MD, FACS
Role of Axillary Ultrasound
Christine Laronga, MD, FACS
Abbreviated MRI: Who, What, Where, and Why?
Christopher Comstock, MD
The Future of Breast Imaging
Aanshu Shah, MD
Q&A

Presidential Address

Presidential Address Introduction
Nathalie Johnson, MD, FACS
“This Is the Moment...”
Julie Margenthaler, MD, FACS

The Great Debates

Moderator: Susan Boolbol, MD, FACS

Welcome and Introduction
Susan Boolbol, MD, FACS
Neoadjuvant Endocrine Therapy Should Be Given to All T2/T3 ER/PR Positive, HER2-negative Breast Cancers (Yes)
Anna Weiss, MD, FACS
Neoadjuvant Endocrine Therapy Should Be Given to All T2/T3 ER/PR Positive, HER2-negative Breast Cancers (No)
Hiram Cody, III, MD, FACS
Axillary Surgery Is Obsolete (Yes)
Theresa Schwartz, MD, MS, FACS
Axillary Surgery Is Obsolete (No)
Armando Giuliano, MD, FACS, FRCSEd

Scientific Oral Presentations I

Moderators: Sarah Blair, MD, FACS; Elizabeth Shaughnessy, MD, PhD, FACS, FSSO

Welcome and Introduction
Sarah Blair, MD, FACS; Elizabeth Shaughnessy, MD, PhD, FACS, FSSO
Oncotype Dx scores and Nodal Status in Patients over 70 years old – Continue to Choose Wisely
Kyra Nicholson, MD
Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members
Emilia Diego, MD, FACS
Text-based Intervention Increases Mammography Uptake Among Overdue Patients at an Urban Safety-net Hospital
Asha Nanda
Economic Impact of Reducing Re-excision Rates after Breast Conserving Surgery in a Large, Integrated Health System
Jeffery Chakedis, MD, FACS
Breast-Specific Sensuality in Breast Cancer Survivors: Sexually Active or Not
Hannah Peifer
Survival Outcomes in Patients Following Locoregional Treatment for DCIS: Analysis of the NCDB DCIS Special Study Cohort
Sabrina Wang

Mitigating Disparities in Medicine

Moderator: Kathie-Ann Joseph, MD, MPH, FACS

Welcome and Introduction
Kathie-Ann Joseph, MD, MPH, FACS
Caring for the Transgender Patient
Marissa Tenenbaum, MD
Screening: What Are the Issues and How Can I Help?
Vivian Bea, MD, MBS, FACS
Racial and Ethnic Differences in Genetics/Genomics
Preeti Subhedar, MD, FACS
Important Considerations in Technology Implementation
Jane Mendez, MD, FACS
Microaggressions in Medicine
Leisha Elmore, MD, MPHS
Q&A

Quickshot Presentations

Moderators: Daniel Leff, FRCS, MS (Hons), PhD; Tracy-Ann Moo, MD, FACS

Welcome and Introduction
Daniel Leff, FRCS, MS (Hons), PhD; Tracy-Ann Moo, MD, FACS
Does Breast-conserving Surgery with Radiotherapy Have a Better Survival Than Mastectomy? A Meta-analysis of More Than 1,500,000 Patients
Manish Karamchandani, MD
A Prospective Clinical Trial of Immediate Breast Reconstruction Following Pre-mastectomy Radiotherapy for Operable Breast Cancer
Puneet Singh, MD
The Effect of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) on the Development of Upper Extremity Lymphedema Following Axillary Lymph Node Dissection in Breast Cancer Patients
Omar Qutob, MD
Axillary Node Positivity Among Suspicious but FNA Negative Nodes
Thomas Robbins
Accuracy of Mammography, Ultrasound, Contrast Enhanced Digital Mammography and MRI on the Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy
Chi Zhang, MD
Young Women with Breast Cancer: Does Surgical Approach Impact Overall Survival?
Christine Pestana, MD
“Practice of Antibiotic Prophylaxis in Patients Undergoing Mastectomy with or without Immediate Reconstruction: A Survey of ASBrS Members.”
Abida Sattar, MD, FACS

Surgical Innovation Forum

Supported by the ASBrS Foundation through a grant from the Melvin and Lynna Silverstein Giving Fund

Moderator: Stacy Ugras, MD, FACS

Welcome and Introduction
Stacy Ugras, MD, FACS
Inflammatory Breast Cancer: Is There a Role for De-Escalation?
Faina Nakhlis, MD, FACS
What Is the Role for Surgery After NAC?
Henry Kuerer, MD, PhD, FACS
Surgery for Stage IV Disease
Mark Basik, MD
Supraclavicular and Contralateral Axillary Disease Management
Suzanne Coopey, MD, FACS
Q&A

Pain Management in Breast Surgery

Moderator: David Brenin, MD, FACS

Welcome and Introduction
David Brenin, MD, FACS
PECS Blocks
Kaitlyn Kennard, MD
ERAS Protocols
Catherine Pesce, MD, FACS
Ethics of Prescribing Opioids
Terry Sarantou, MD, FACS
Q&A

Best Papers of 2021

Best Papers of 2021
Helen Pass, MD, FACS

Plastic Surgery Corner

Moderator: Shawna Willey, MD, FACS

Welcome and Introduction
Shawna Willey, MD, FACS
Updates on Implants and ALCL
Terence Myckatyn, BSc(Hon), MD
Surgery for Lymphedema: LYMPHA, Lymph Node Transfer, and More!
Aladdin Hassanein, MD, MMSc, FACS
Going Flat Aesthetic Closures
Deanna Attai, MD, FACS
Access for Reconstruction: Is It an Issue?
Sharon Lum, MD, FACS
Q&A

Keynote Address: “When Is Local Therapy Enough?”

Keynote Address Introduction
Julie Margenthaler, MD, FACS
“When Is Local Therapy Enough?”
V. Suzanne Klimberg, MD, PhD, MSHCT, FACS

The Patient Perspective

Moderator: Betty Fan, DO, FACS

Welcome and Introduction
Betty Fan, DO, FACS
Breast Cancer as a Young Mother
Jennifer Farmer
Living With Metastatic Disease
Jennifer Brown
Survivorship After Breast Cancer for the Breast Surgeon
Jennifer O'Neill, MD, FACS
Q&A

Scientific Oral Presentations II

Moderators: Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS; Mediget Teshome, MD, MPH, FACS

Welcome and Introduction
Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS; Mediget Teshome, MD, MPH, FACS
Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk and Age
Judy Boughey, MD, FACS
Is Nodal Clipping Beneficial for Patients Receiving Neoadjuvant Chemotherapy?
Giacomo Montagna, MD, MPH
Intervention to Hepatic and Pulmonary METastases in Breast Cancer Patients: Prospective, Multi-Institutional Registry Study-IMET; Protocol MF 14-02
Atilla Soran, MD, MPH, FNBC, FACS
A DCIS Biosignature with a Novel Residual Risk Subtype Identifies Patients with Varying Risk and RT Benefit Among Younger and High Grade DCIS Patients
Brian Czerniecki, MD, PhD, FACS
Impact of Loco-regional Treatment on Survival in Young Patients with Operable Breast Cancer
Javier Orozco, MD, MSc
The Male WhySurg Study: Patient and Surgeon Experience
Anna Chichura, MD

“How I Do It” Videos

Moderator: Abhishek Chatterjee, MD, MBA, FACS

Welcome and Introduction
Abhishek Chatterjee, MD, MBA, FACS
Early BIA-ALCL. From Diagnosis to Treatment
Gonzalo Ziegler Rodriguez, MD
Q&A
The Single Port Robotic Nipple Sparing Mastectomy
Deborah Farr, MD, FACS
Q&A
Prophylactic Lympho-Venous Bypass following Axillary Lymph Node Dissection (Simple LYMPHA)
James Jakub, MD, FACS
Q&A
Gender-Affirming Bilateral Mastectomy with Free Nipple Grafting
Jeffrey Sugandi, MD
Q&A

Latest Developments

Moderator: Brigid Killelea, MD, MPH, FACS

Welcome and Introduction
Brigid Killelea, MD, MPH, FACS
Clinical Trials to Know About Right Now
Roshni Rao, MD
Medical Therapy
Jennifer Matro, MD
Ablative Techniques
Sheldon Feldman, MD, FACS
Q&A

De-escalating and Escalating Radiation

Moderator: Katherine Glover-Collins, MD, PhD

Welcome and Introduction
Katherine Glover-Collins, MD, PhD
Gene Profiling for Adjuvant Radiation
Stephanie Valente, DO, FACS
Beyond the Breast: The Role of Regional Radiation
Richard Zellars, MD
Assessing the Need for Radiation After NAC
Meena Moran, MD
IORT: Where Do We Stand?
Nathalie Johnson, MD, FACS
Q&A

Survivorship and Beyond

Moderator: Sarah McLaughlin, MD, FACS

Welcome and Introduction
Sarah McLaughlin, MD, FACS
Building a Successful Survivorship Program
Paul Baron, MD, FACS
Sex After Breast Cancer
Shayna Showalter, MD, FACS
What Is Exercise Oncology and How Can It Help My Patients?
Kathryn Schmitz, PhD, MPH
Financial Toxicity in Breast Cancer Patients
Rachel Greenup, MD, MPH, FACS
Q&A

Most Requested Topics in Benign Breast Diseases

Moderator: Lucy De La Cruz, MD

Welcome and Introduction
Lucy De La Cruz, MD
Granulomatous Mastitis
Atilla Soran, MD, MPH, FNBC, FACS
Breast Diseases During Pregnancy and Lactation
Katrina Mitchell, MD, FACS
Papilloma: To Excise or Not to Excise?
Kandice Ludwig, MD, FACS
Phyllodes
Richard Barth, Jr., MD, FACS
Abscess, Zuska’s Disease, and Fistulas
Howard Snider, Jr., MD, FACS
Breast Pain
Kristalyn Gallagher, DO, FACOS, FACS
Q&A

Creating Longevity for Breast Surgeons

Moderator: Alyssa Throckmorton, MD, FACS

Welcome and Introduction
Alyssa Throckmorton, MD, FACS
Media Training
Gregory Boller, PhD
How To Prevent Burnout
Ronda Henry-Tillman, MD, FACS
Ergonomics in the OR
Katherine Kopkash, MD, FACS
2025 Is Here!
Walton Taylor, MD, FACS
Q&A

Agenda

The Online Experience Is Open!